Authors:
KAPIL RP
EMM TA
MOUSA SA
PADOVANI PK
QUON CY
LAM GN
Citation: Rp. Kapil et al., BIOLOGICAL MATRIX-DEPENDENT PHARMACOKINETIC AND PHARMACODYNAMIC PARAMETERS OF A NOVEL PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR ANTAGONIST, XU063, IN BEAGLE DOGS/, Thrombosis research, 86(3), 1997, pp. 221-232
Citation: Ta. Emm et al., DETERMINATION OF XR510, A BALANCED ANGIOTENSIN-II RECEPTOR ANTAGONIST, IN DOG AND RAT PLASMA BY COMBINED LIQUID-LIQUID SOLID-PHASE EXTRACTION AND HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical applications, 675(2), 1996, pp. 273-278
Citation: Af. Davidson et al., DETERMINATION OF NALTREXONE AND ITS MAJOR METABOLITE, 6-BETA-NALTREXOL, IN HUMAN PLASMA USING LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION, Journal of pharmaceutical and biomedical analysis, 14(12), 1996, pp. 1717-1725
Authors:
WU ST
STAMPFLI HF
BANKS CM
EMM TA
KAPIL RP
PADOVANI PK
LEE WM
HUANG SM
Citation: St. Wu et al., DETERMINATION OF DMP-728, A IIB IIIA RECEPTOR ANTAGONIST, IN RAT AND DOG PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUOROMETRICDETECTION/, Journal of chromatography B. Biomedical applications, 657(1), 1994, pp. 254-260